Clinical trial
Paliperidone Palmitate in Early Schizophrenia - A Retrospective, Non-interventional Study of Patients With Newly Diagnosed Schizophrenia Treated With Paliperidone Palmitate Over a 12-Month Period
NCT02532842 is registered in ClinicalTrials.gov with Janssen Pharmaceutica N.V., Belgium as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Paliperidone Palmitate in Early Schizophrenia - A Retrospective, Non-interventional Study of Patients With Newly Diagnosed Schizophrenia Treated With Paliperidone Palmitate Over a 12-Month Period
- Lead sponsor
- Janssen Pharmaceutica N.V., Belgium
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2015
- Completion date
- September 30, 2015
- Enrollment
- 90 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.